mTOR阻害剤の世界市場 (2023-2030年)：規模・シェア・予測 (タイプ・用途・地域/国別)・COVID-19の影響分析

mTOR阻害剤の市場規模は、2022年の60億820万米ドルから、2030年にかけては5.1％のCAGRで成長すると予測されています。

当レポートでは、世界のmTOR阻害剤の市場を調査し、市場概要、市場影響因子の分析、法規制の枠組み、COVID-19の影響、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、市場シェア、主要企業のプロファイル、アナリストの見解などをまとめています。

目次

第1章 mTOR阻害剤：市場概要

第2章 エグゼクティブサマリー

第3章 mTOR阻害剤：主要市場動向

• 市場促進要因
• 市場抑制要因
• 市場機会
• 市場の今後の動向

第4章 mTOR阻害剤：産業調査

• PEST分析
• ポーターのファイブフォース分析
• 成長見通しマッピング
• 規制の枠組み

第5章 mTOR阻害剤市場：COVID-19の影響分析

• COVID-19以前の影響分析
• COVID-19後の影響分析

第6章 mTOR阻害剤：市場情勢

• 市場シェア分析
• 内訳データ：主要製造業者別

第7章 mTOR阻害剤市場：タイプ別

第8章 MTOR阻害剤市場：用途別

第9章 mTOR阻害剤市場：地域別

• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第10章 主要ベンダー分析： mTOR阻害剤産業

• 競合ダッシュボード
• 企業プロファイル
  • Novartis AG
  • Pfizer Inc.
  • AstraZeneca plc
  • Sanofi SA
  • Merck & Co., Inc.
  • Roche Holding AG
  • AbbVie Inc.
  • Takeda Pharmaceutical Company Limited
  • Intellia Therapeutics, Inc.
  • Gilead Sciences, Inc.
  • Celgene Corporation (now part of Bristol Myers Squibb)
  • Exelixis, Inc.
  • MedImmune, LLC (a subsidiary of AstraZeneca plc)
  • Johnson & Johnson
  • Bayer AG

第11章 アナリストの見解

第12章 付録

List of Tables

• TABLE List of data sources
• TABLE Market drivers; Impact Analysis
• TABLE Market restraints; Impact Analysis
• TABLE MTOR Inhibitors Market: Type Snapshot (2022)
• TABLE Segment Dashboard; Definition and Scope, by Type
• TABLE Global MTOR Inhibitors Market, by Type2018-2030 (USD Million)
• TABLE MTOR Inhibitors Market: ApplicationSnapshot (2022)
• TABLE Segment Dashboard; Definition and Scope, by Application
• TABLE Global MTOR Inhibitors Market, by Application2018-2030 (USD Million)
• TABLE MTOR Inhibitors Market: Regional snapshot (2022)
• TABLE MTOR Inhibitors Market: Technology Snapshot (2022)
• TABLE Segment Dashboard; Definition and Scope, by Technology
• TABLE Global MTOR Inhibitors Market, by Technology 2018-2030 (USD Million)
• TABLE Segment Dashboard; Definition and Scope, by Region
• TABLE Global MTOR Inhibitors Market, by Region 2018-2030 (USD Million)
• TABLE North America MTOR Inhibitors Market, by Country, 2018-2030 (USD Million)
• TABLE North America MTOR Inhibitors Market, by Type, 2018-2030 (USD Million)
• TABLE North America MTOR Inhibitors Market, by Application, 2018-2030 (USD Million)
• TABLE North America MTOR Inhibitors Market, by Technology, 2018-2030 (USD Million)
• TABLE Europe MTOR Inhibitors Market, by Country, 2018-2030 (USD Million)
• TABLE Europe MTOR Inhibitors Market, by Type, 2018-2030 (USD Million)
• TABLE EuropeMTOR Inhibitors Market, by Application, 2018-2030 (USD Million)
• TABLE Europe MTOR Inhibitors Market, by Technology, 2018-2030 (USD Million)
• TABLE Asia Pacific MTOR Inhibitors Market, by Country, 2018-2030 (USD Million)
• TABLE Asia Pacific MTOR Inhibitors Market, by Type, 2018-2030 (USD Million)
• TABLE Asia Pacific MTOR Inhibitors Market, by Application, 2018-2030 (USD Million)
• TABLE Asia Pacific MTOR Inhibitors Market, by Technology, 2018-2030 (USD Million)
• TABLE Latin America MTOR Inhibitors Market, by Country, 2018-2030 (USD Million)
• TABLE Latin America MTOR Inhibitors Market, by Type, 2018-2030 (USD Million)
• TABLE Latin America MTOR Inhibitors Market, by Application, 2018-2030 (USD Million)
• TABLE Latin America MTOR Inhibitors Market, by Technology, 2018-2030 (USD Million)
• TABLE Middle East and Africa MTOR Inhibitors Market, by Country, 2018-2030 (USD Million)
• TABLE Middle East and Africa MTOR Inhibitors Market, by Type, 2018-2030 (USD Million)
• TABLE Middle East and Africa MTOR Inhibitors Market, by Application, 2018-2030 (USD Million)
• TABLE Middle East and Africa MTOR Inhibitors Market, by Technology, 2018-2030 (USD Million)

List of Figures

• FIGURE MTOR InhibitorsMarket Segmentation
• FIGURE Market research methodology
• FIGURE Value chain analysis
• FIGURE Porter's Five Forces Analysis
• FIGURE Market Attractiveness Analysis
• FIGURE COVID-19 Impact Analysis
• FIGURE Pre & Post COVID-19 Impact Comparision Study
• FIGURE Competitive Landscape; Key company market share analysis, 2022
• FIGURE Type segment market share analysis, 2022&2030
• FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Application segment market share analysis, 2022&2030
• FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Technology segment market share analysis, 2022&2030
• FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Regional segment market share analysis, 2022&2030
• FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE North America MTOR Inhibitors Market share and leading players, 2022
• FIGURE Europe MTOR Inhibitors Market share and leading players, 2022
• FIGURE Asia Pacific MTOR Inhibitors Market share and leading players, 2022
• FIGURE Latin America MTOR Inhibitors Market share and leading players, 2022
• FIGURE Middle East and Africa MTOR Inhibitors Market share and leading players, 2022
• FIGURE North America market share analysis by country, 2022
• FIGURE U.S. MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Canada MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Europe MTOR Inhibitors Market share analysis by country, 2022
• FIGURE Germany MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Spain MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Italy MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE France MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE UK MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Russia MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE NetherlandsMTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE SwedenMTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE PolandMTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Rest of the Europe MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Asia Pacific MTOR Inhibitors Market share analysis by country, 2022
• FIGURE India MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE China MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Japan MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE South Korea MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE AustraliaMTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE ThailandMTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE IndonesiaMTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE PhillipinesMTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Rest of APAC MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Latin America MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Latin America MTOR Inhibitors Market share analysis by country, 2022
• FIGURE Brazil MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Mexico MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Argentina MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE ColombiaMTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Rest of LATAM MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Middle East and Africa MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Middle East and Africa MTOR Inhibitors Market share analysis by country, 2022
• FIGURE Saudi Arabia MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE United Arab Emirates MTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE IsraelMTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE TurkeyMTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE AlgeriaMTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE EgyptMTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Rest of MEAMTOR Inhibitors Market size, forecast and trend analysis, 2018 to 2030 (USD Million)

REPORT HIGHLIGHT

mTOR Inhibitors Market size was valued at USD 6,008.2 Million in 2022, expanding at a CAGR of 5.1% from 2023 to 2030.

mTOR inhibitors, which stand for mechanistic target of rapamycin inhibitors, are a highly effective class of drugs that target the mTOR pathway - a vital cellular signaling pathway responsible for regulating cell growth, proliferation, and survival. By targeting the activity of mTOR, which is often overactive in various cancers and other diseases, mTOR inhibitors can slow down the progression of the disease and potentially improve patient outcomes. Currently, there are two classes of mTOR inhibitors available: rapalogs and ATP-competitive inhibitors. Rapalogs, such as sirolimus and everolimus, are designed to mimic the structure of rapamycin, a natural mTOR inhibitor.

MTOR Inhibitors Market- Market Dynamics

The global mTOR inhibitors market is poised for significant growth, driven by several key factors. One of the major growth drivers is the increasing incidence of cancer, which has created a pressing need for effective treatment options. Additionally, the rising prevalence of kidney transplantation due to organ shortage is contributing to the growth of the market, as mTOR inhibitors are used as immunosuppressant agents to prevent organ rejection.

The growing geriatric population is also a significant factor driving market growth. As the population ages, there is an increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases, which require long-term treatment with drugs such as mTOR inhibitors. Furthermore, rising demand for novel therapies and advances in medical technologies are expected to drive the market growth during the forecast period.

MTOR Inhibitors Market- Segmentation Analysis:

The Global MTOR Inhibitors Market is segmented on the basis of Type, Application and Region.

On the basis of Type, the market is segmented into Rapamune, Torisel, Afinitor, and Zortress. Rapamune is a highly effective mTOR inhibitor used to treat cancer and prevent organ rejection in transplant patients. This drug works by slowing down the growth of tumors and inhibiting the production of white blood cells, which helps to prevent organ rejection. As an immunosuppressant, Rapamune works by decreasing the activity of the immune system to prevent it from attacking the transplanted organ or tissue. The drug is available in capsule form and is typically taken once a day with water. The duration of treatment with Rapamune is generally up to one year, but it may be stopped earlier if testing shows that the patient no longer needs the medication.

On the basis of Application, the market is segmented into Tumor Treatment, Kidney Transplant. The use of mTOR inhibitors in kidney treatment has several specific applications. One such application is for the treatment of Wilm's tumor, a type of tumor that develops on the surface of the kidneys. mTOR inhibitors have shown promise in treating this condition by inhibiting the growth of the tumor.

MTOR Inhibitors Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Throughout the forecasted years, North America region has dominated the majority of the market share in the mTOR inhibitors market. The region's rapid growth in healthcare expenditure, presence of key players and advanced healthcare facilities, and increasing number of elderly populations have contributed to the growth of the mTOR inhibitors market in North America. In contrast, the Asia-Pacific region is projected to achieve the fastest CAGR from 2022 to 2030. This can be attributed to several factors such as the surging number of cancer patients, rising government initiatives toward drug development, and growing awareness for novel treatments. In addition, the increasing prevalence of chronic diseases and growing healthcare infrastructure are also driving the market growth in the Asia-Pacific region.

As the demand for mTOR inhibitors continues to rise, key players in the market are expanding their operations and investing in research and development to bring new drugs to the market. With the increasing adoption of these drugs, the mTOR inhibitors market is expected to witness substantial growth globally in the coming years.

MTOR Inhibitors Market-Competitive Landscape:

mTOR inhibitors market is highly competitive, with several key players investing in the development of new and innovative therapies. The success of these players will depend on their ability to develop effective therapies that can overcome the challenges of drug resistance and side effects, as well as their ability to navigate the complex regulatory landscape and meet the changing needs of patients and healthcare providers.

Novartis AG is one of the leading players in the mTOR inhibitors market, with its drug everolimus (brand name Afinitor) approved for the treatment of several types of cancer, including renal cell carcinoma and pancreatic neuroendocrine tumors. The company has also invested in the development of combination therapies, such as the combination of everolimus and exemestane for the treatment of breast cancer.

Key features of the study:

This proposed research study on MTOR Inhibitors Market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for MTOR Inhibitors Market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the MTOR Inhibitors Market

Impact of COVID-19 on MTOR Inhibitors Market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on MTOR Inhibitors Market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the MTOR Inhibitors Market, we have also included competitive landscape and key innovator analysis for the MTOR Inhibitors Market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offersdetailed company profiling featuring major market participantswhich will help users to understand their financial information and strategic initiatives of players operating in the MTOR Inhibitors Market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The global MTOR Inhibitors Market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MTOR INHIBITORS MARKET KEY PLAYERS

Novartis AG

Pfizer Inc.

AstraZeneca plc

Sanofi SA

Merck & Co., Inc.

Roche Holding AG

AbbVie Inc.

Takeda Pharmaceutical Company Limited

Intellia Therapeutics, Inc.

Gilead Sciences, Inc.

Celgene Corporation (now part of Bristol Myers Squibb)

Exelixis, Inc.

MedImmune, LLC (a subsidiary of AstraZeneca plc)

Johnson & Johnson

Bayer AG

GLOBAL MTOR INHIBITORS MARKET, BY TYPE

Rapamune

Torisel

Afinitor

Zortress

GLOBAL MTOR INHIBITORS MARKET, BY APPLICATION

Tumor Treatment

Kidney Transplant

Others

GLOBAL MTOR INHIBITORS MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Russia

Netherlands

Sweden

Poland

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Australia

Thailand

Indonesia

Philippines

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Colombia

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Israel

Turkey

Algeria

Egypt

Rest of MEA

TABLE OF CONTENT

1. MTOR Inhibitors Market Overview

• 1.1. Study Scope

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. MTOR Inhibitors Market Snippet by Type
  • 2.1.2. MTOR Inhibitors Market Snippet by Application
  • 2.1.3. MTOR Inhibitors Market Snippet by Country
  • 2.1.4. MTOR Inhibitors Market Snippet by Region
• 2.2. Competitive Insights

3. MTOR Inhibitors Key Market Trends

• 3.1. MTOR Inhibitors Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. MTOR Inhibitors Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. MTOR Inhibitors Market Opportunities
• 3.4. MTOR Inhibitors Market Future Trends

4. MTOR Inhibitors Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. MTOR Inhibitors Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. MTOR Inhibitors Market Landscape

• 6.1. MTOR Inhibitors Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. MTOR Inhibitors Market - By Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Type, 2022&2030 (%)
  • 7.1.2. Rapamune
  • 7.1.3. Torisel
  • 7.1.4. Afinitor
  • 7.1.5. Zortress

8. MTOR Inhibitors Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
  • 8.1.2. Tumor Treatment
  • 8.1.3. Kidney Transplant
  • 8.1.4. Others

9. MTOR Inhibitors Market- By Geography

• 9.1. Introduction
  • 9.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
• 9.2. North America
  • 9.2.1. Overview
  • 9.2.2. MTOR Inhibitors Key Manufacturers in North America
  • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.2.6. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.2.7. U.S.
    • 9.2.7.1. Overview
    • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7.5. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.2.8. Canada
    • 9.2.8.1. Overview
    • 9.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.8.5. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
• 9.3. Europe
  • 9.3.1. Overview
  • 9.3.2. MTOR Inhibitors Key Manufacturers in Europe
  • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3.6. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.3.7. Germany
    • 9.3.7.1. Overview
    • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7.5. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.3.8. Italy
    • 9.3.8.1. Overview
    • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8.5. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.3.9. United Kingdom
    • 9.3.9.1. Overview
    • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9.5. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.3.10. France
    • 9.3.10.1. Overview
    • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10.5. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.3.11. Russia
    • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11.4. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.3.12. Netherlands
    • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12.4. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.3.13. Sweden
    • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13.4. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.3.14. Poland
    • 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14.4. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.3.15. Rest of Europe
    • 9.3.15.1. Overview
    • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.15.5. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
• 9.4. Asia Pacific (APAC)
  • 9.4.1. Overview
  • 9.4.2. MTOR Inhibitors Key Manufacturers in Asia Pacific
  • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4.6. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.4.7. India
    • 9.4.7.1. Overview
    • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7.5. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.4.8. China
    • 9.4.8.1. Overview
    • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8.5. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.4.9. Japan
    • 9.4.9.1. Overview
    • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9.5. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.4.10. South Korea
    • 9.4.10.1. Overview
    • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10.5. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.4.11. Australia
    • 9.4.11.1. Overview
    • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11.5. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.4.12. Thailand
    • 9.4.12.1. Overview
    • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12.5. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.4.13. Indonesia
    • 9.4.13.1. Overview
    • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13.5. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.4.14. Philippines
    • 9.4.14.1. Overview
    • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.14.3. PhilippinesMarket Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.14.4. PhilippinesMarket Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14.5. PhilippinesMarket Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.4.15. Rest of APAC
    • 9.4.15.1. Overview
    • 9.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.15.5. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
• 9.5. Latin America
  • 9.5.1. Overview
  • 9.5.2. MTOR Inhibitors Key Manufacturers in Latin America
  • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5.6. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.5.7. Brazil
    • 9.5.7.1. Overview
    • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7.5. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.5.8. Mexico
    • 9.5.8.1. Overview
    • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8.5. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.5.9. Argentina
    • 9.5.9.1. Overview
    • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9.5. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.5.10. Colombia
    • 9.5.10.1. Overview
    • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10.5. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.5.11. Rest of LATAM
    • 9.5.11.1. Overview
    • 9.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.11.5. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
• 9.6. Middle East and Africa
  • 9.6.1. Overview
  • 9.6.2. MTOR Inhibitors Key Manufacturers in Middle East and Africa
  • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.6.7. Saudi Arabia
    • 9.6.7.1. Overview
    • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7.5. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.6.8. United Arab Emirates
    • 9.6.8.1. Overview
    • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8.5. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.6.9. Israel
    • 9.6.9.1. Overview
    • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.9.3. IsraelMarket Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.9.4. IsraelMarket Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9.5. IsraelMarket Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.6.10. Turkey
    • 9.6.10.1. Overview
    • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10.5. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.6.11. Algeria
    • 9.6.11.1. Overview
    • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11.5. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.6.12. Egypt
    • 9.6.12.1. Overview
    • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12.5. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 9.6.13. Rest of MEA
    • 9.6.13.1. Overview
    • 9.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.13.5. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- MTOR Inhibitors Industry

• 10.1. Competitive Dashboard
• 10.2. Company Profiles
  • 10.2.1. Novartis AG
  • 10.2.2. Pfizer Inc.
  • 10.2.3. AstraZeneca plc
  • 10.2.4. Sanofi SA
  • 10.2.5. Merck & Co., Inc.
  • 10.2.6. Roche Holding AG
  • 10.2.7. AbbVie Inc.
  • 10.2.8. Takeda Pharmaceutical Company Limited
  • 10.2.9. Intellia Therapeutics, Inc.
  • 10.2.10. Gilead Sciences, Inc.
  • 10.2.11. Celgene Corporation (now part of Bristol Myers Squibb)
  • 10.2.12. Exelixis, Inc.
  • 10.2.13. MedImmune, LLC (a subsidiary of AstraZeneca plc)
  • 10.2.14. Johnson & Johnson
  • 10.2.15. Bayer AG

11. 360 Degree Analyst View

12. Appendix

• 12.1. Research Methodology
• 12.2. References
• 12.3. Abbreviations
• 12.4. Disclaimer
• 12.5. Contact Us